Headquartered in London and manufacturing in Denmark, Contura CEO, Rakesh Tailor, takes a tour of the Danish facility.
Contura’s state-of-the-art manufacturing facility in Denmark has over 20 years of experience producing 2.5 iPAAG (hydrogel) injectables and is certified according to EU, US and other international standards, using proprietary technology and stringent quality control measures to deliver the highest quality products.
Solely dedicated to the production of 2.5 iPAAG, the facility uses proprietary automated processes to control manufacturing, including the ALPH (Automated Line for Production of Hydrogel), a one-of-a-kind machine designed specifically for Contura. ALPH’s advanced capabilities and design reflect their commitment to innovation and excellence in hydrogel production.
Contura has a team of highly qualified scientists and engineers who oversee the production process and ensure our syringes are tightly monitored to meet release specifications.